Thank you for downloading and welcome to Take Orally, the emergency medicine podcast recorded at Dream, Queen's Medical Center at Nottingham. In this episode we'll be discussing COPD. As ever, all information is correct at the time of recording. Any guidelines mentioned are correct for Nottingham University Hospitals NHS Trust. Other trust guidelines may vary. All opinions are the speaker's own.
Hello, my name is Jamie. I'm one of the teaching fellows in emergency medicine. And I'm Charlie. I'm one of the teaching fellows in emergency medicine and general medicine. Welcome back to Take Orly, Charlie. Hello. So a few months back, it seems much longer than that, we went through the asthma podcast. Today we are going to tackle COPD. Seems only right. So first up, Charlie, what is COPD and who gets it? So COPD stands for chronic obstructive pulmonary disease. And it basically is what it says. It's a chronic condition that affects the lungs. Similar to asthma, it's an obstructive.
pathology and so it's obstruction of the airways there is still an element of reversibility but not fully reversible as I say it's progressive so generally might start off with quite mild symptoms and progresses into more severe disease it traditionally was divided into sort of an emphysematous picture and a chronic bronchitis picture that definition has sort of disappeared a little bit and most people do have elements of both that idea of destruction of the alveoli as well as the sort of chronic inflammation narrowing of the bronchi that causes that airway obstruction now The most common cause which everyone knows about is smoking, and I think 90% of people who have COPD are either smokers or ex-smokers. Not all smokers, however, progress to get COPD, and it may be just 20% or 30% that actually get COPD. There is an occupational link, so toxins, chemicals can also cause a COPD-like picture, and there is potentially a genetic link or genetic predisposition, something called alpha-1 antitryptin deficiency can predispose people to getting this sort of airway disease.
I think now there's about 3 million people, they reckon, in the UK that have COPD, 2 million of these possibly undiagnosed. The majority of people get diagnosed over 50, and it's very rare, really, to have COPD under the age of 35. So I think you may encounter patients who may have been diagnosed before the term of COPD came about, so saying, oh, I have emphysema doctor, my GP's told me I've got bronchitis doctor, and actually it all fits under this umbrella term now. Yeah, and that's not the only exclusive pathophysiology here. It's the main ones that we see, and as I say, you'll see a combination of both on CT.
CT scans. And the alpha-1 antitrypsin is a protease inhibitor. I did a bit of reading before it came in. And also is linked to hepatitis, cirrhosis, and also linked to inflammatory bowel disease. Sort of this overall inflammatory process of the body. Cool. So, as I said before, shortness of breath, such a common presentation in A&E. What's sort of the key history bits of our patient with shortness of breath that would point towards COPD?
So, I mean, one thing to think about is the fact that you may only see them in secondary care after a period of time. They may or may not have received a label by this time, but you may get that idea of progressive shortness of breath, the idea that initially it was mild and exertional breathlessness only, and eventually sort of progressing to sort of breathlessness even at rest at minimal exertion. And there is this MRC dyspnea scale, which rates from sort of one to five, five being breathless even when dressing, sort of minimal activity. The other history bits to look out for are the idea of this recurrent cough, people who really can't shift a cough. You'll find that it's very productive. Most commonly in the morning they will bring up a lot of sputum, and the things to look out for for exacerbations is that quantity or colour of sputum changing. Similar to asthma, them both being obstructive airways diseases, look out for that chest tightness, the wheezing as well. The other thing that happens with COPD patients and that idea of progressiveness of the disease is that they will also encounter frequent exacerbations, and actually that can be part of the diagnostic criteria, that idea of frequent winter episodes of bronchitis.
With the progressive nature of the disease as well, you will also see elements of right-sided heart failure as you get vascular disease in the lungs as well. That term is called pulmonale, and therefore you may get patients presenting with evidence of heart failure as well. So the core pulmonale picture might be a right heart failure as well as showing signs of obstructive lung disease as well? Yeah, absolutely. So you'd still get the wheezing, the chest tightness, the shortness of breath, the productive cough, but you will see patients that get the ankle swelling. Obviously that might be more peripheral edema, but you might see pleural effusions and some sort of pulmonary edema as well. Okay. Also, heart failure also conditioned.
showing a progressive shortness of breath on exertion with increasing limitation on life quality. OK, so we talked a bit in the podcast about what features might point towards an asthma diagnosis. Shall we just again just go over again looking at COPD versus asthma? So what clues might point towards COPD rather than asthma? So, I mean, the main thing really is to think about the history in these patients and the age that they're presenting. As I say, it'd be very rare for someone to actually be diagnosed with COPD under the age of 35, whereas, as we know, asthmatics tend to get diagnosed at a younger age. The symptoms they will get is more that sort of nocturnal symptoms, the cough, wheeze at night, and a variable sort of diurnal change in their symptoms, whereas COPD patients tend to have sort of persistent and progressive breathlessness and, as I say, will nearly always have a smoking history.
So again, it's history, history, history. You can't escape your history, can you? So, okay, we have a patient, they are a smoker or an ex-smoker, we suspect COPD, but how are we actually going to definitively diagnose it in our patient? Well, interestingly, I mean, the clinical symptoms really are the most important part of the diagnostic process. That idea of smoking history, even exposure to secondhand smoke is a really important thing to sort of elicit as well, or the occupational exposure, which I mentioned before.
Bedside tests, spirometry is really important, and we'll go on to that with sort of the definition, sort of facts and figures in a minute. But that idea of looking for an obstructive deficit in contrast to what you would see in pulmonary fibrosis, where you'd get that restrictive deficit. Important to always do an ECG. Some people will present with angina and breathlessness. So make sure you're doing ECG, certainly in those patients who have the risk factors, that over 60s, smokers, make sure you're excluding cardiac pathology. Also ACS risk factors. Absolutely.
I mean, a simple thing in terms of people who present with that productive cough as well, think about your sputum cultures. That's also just a treatment point of view. Microbiology department. Thank you for reminding us on that one. Further tests. In hospital, we'll do ABGs, and you might see that sort of chronic respiratory acidosis, that high PCO2, high bicarb. Imaging-wise, they'll nearly always have had a chest x-ray at some point, that two-week wait for a productive cough. But you'll see that hyper-expansion of the chest.
We move on then to CT, where you'll see, as I mentioned before, the emphysematis changes, that chronic inflammation. And finally, with regards to the sort of edema, and again, differentiating between COPD and heart failure, you might think about echo. And actually, that is a really important part of the BTS guidelines, is to be excluding other pathology. So you mentioned arterial blood gases there, and I suppose the classic picture you're going to see there is a hypercapnic patient, but with a raised serum bicarb in order to compensate for that, so a metabolic compensation for respiratory acidosis. Yeah, I mean, certainly in the...
I think it's most often the later stages, but again, not everybody. You will see that CO2 retention and that chronic metabolic compensation, which we then see sort of acutely deteriorating to give a sort of respiratory acidosis. But there are COPD patients who... don't retain CO2 and they're the ones that we still accept the SATs greater than 94 rather than the retainers where we are more controlled with our oxygen therapy and accept SATs 88 to 92. So that's the concept of the hypoxic drive in those patients who are retaining CO2 rather than a hypocapnic drive. Absolutely, so you will see a chronic retainer who is given too much oxygen will retain more carbon dioxide and become more drowsy, more acidotic and becomes a sort of preterminal event so it's a really important thing to be aware of. This is something that I have seen in A&E a few times,
over generous use of oxygen pre-hospital on a patient where it's maybe not known that they have COPD and a very drowsy doctor and you get these looks when you actually turn off the oxygen that they're on and it's like oh where am I I thought I was in yeah so I think so many are undiagnosed I mean no one's doing anything wrong giving them oxygen a hypoxia will kill someone with undiagnosed respiratory conditions that's of 80 of course you're going to give them oxygen And that's certainly something, again, when I'm speaking in A&E onto the respiratory team, like you said, this concept, you know, if I have a patient who is, you know, a smoker coming in and I look at their gas, an ABG, and they do have maybe a ratio to, or they're raised by a car, we're starting to think, well, hang on, this patient may be an undiagnosed. So we've got these methods for diagnosing, but then how do we...
definitively, you know, clinically define COPD? So as I say, the hard numbers are based on spirometry, and the two things we look at are the FEV1 and the FEC, and in fact it's the ratio of FEV1 to FEC that gives us our definition, and the air flow obstruction will be a reduced ratio, so a ratio less than 1, and the definition is less than 0.7. Now, you can still diagnose COPD in someone who has a ratio or an FEV1 greater than 80% predicted, as long as it's in the presence of convincing symptoms. And that FEV1 will then guide us to how severe our patient COPD is.
So we tend to say, I mean, there are different classifications, and interestingly, the definitions tend to be based on a sort of post-bronchodilator FEV1, so that means you've given them salbutamol to assess that reversibility. Someone who has an FEV1 of sort of 50 to 80% of their predicted is sort of diagnosed as mild or moderate in some cases, level of COPD. You've got that 30 to 50, sort of moderate to severe. Less than 30% predicted at FEV1 is sort of severe, and some classifications even very severe. Okay, so we'll go into the acute management but first I think what will be the chronic management then or the community based management, the secondary management for a patient coming in with COPD? So needless to say, simple things first, lifestyle measures, stop smoking, reduce that occupation exposure if you can. Even if they already have COPD? Even if they already have it, it will just continue to exacerbate the disease so stopping smoking is one of the most important things that they can do.
Another thing that is nice guidelines and actually I think the only thing with any proven benefit is pulmonary rehabilitation in terms of mortality. I mean that's just breathing exercises and it's something that everyone should be offered and a lot of people do take up. Medications-wise, bronchodilators, so your short-acting salbutamol in the same way you would with asthma, or long-acting bronchodilators as well, salmetrol, we use too. Again, you'd use your inhaled corticosteroids in a sort of chronic management. And what you'll see more commonly used in COPD as a sort of long-term management, as opposed to asthma, is the use of long-acting muscarinic antagonists. So that's teotropium.
Again, something different to asthma is the mucolytic. So carbocysteine, you'll see a lot of people on it, and that's just how much of the protein production that they get. So again, if you see a patient, oh, I have asthma doctrine, you see them in their drug box, you think, maybe not. Yeah, and again, your history will probably point in that direction as well. Some people may need systemic corticosteroids long-term as well, and certainly you'll see patients who have recurrent acute prescriptions of steroids needing weaning doses as well, in the same way you would with asthma. That's a really important thing to consider. Don't forget the gastro protection with your steroids as well. Very important, yes. And finally, the other things that are considered in COPD in particular, certainly thinking about it being a progressive disease and occurring later in life and potentially being a preterminal diagnosis, is the use of long-term oxygen therapy. And again, that's based on a criteria of having chronic hypoxia.
and that will be installed into their home and they can have long-term oxygen therapy and even have canisters to go out as well. And in some cases, we do use non-invasive ventilation sort of chronically as well, particularly, as I say, for the hypercapnic COPD patients. Okay, so we'll talk a bit more about NIV in a little while. So that's our patients in the community, and I think very useful to take that sort of information to get an idea, you know, is my patient coming in with COPD on oxygen at home, if so, for how long and how much, etc. Okay, so the acute management then of our patient coming in with an exacerbation of his or her COPD. So I think it's important to think about the fact that you might have an infective exacerbation, which is what perhaps we're more familiar with, so the idea of even a viral exacerbation, knocking someone's COPD off.
people will have complications of their COPD for other reasons as well. So that COPD patient who has had codeine acutely for arthritis, knock off their respiratory drive, you're going to, again, send them into that decompensated respiratory failure. So do just think about the cause of them decompensating. In terms of the sort of infective side of things, which we'll talk about primarily, a lot of COPD patients will have what they call rescue treatment in the community. So they will have a steroid and an antibiotic that they will have at home to initiate as soon as they get symptoms. And that may be how they're managed acutely.
Often that will have occurred and two days down the line they're still not well enough and they'll end up coming into hospital. So it's just to be aware that they may not be on those two chronically but they may have started them acutely. So the treatment's the same once you come into hospital. You're going to think about steroids, whether or not they can take them orally or you'd give them IV. So prednisolone orally, hydrocortisone IV. Similar doses as your asthma exacerbations as well. So a lot of people get prescribed 30 for pred, some people say 40, some even go up to 50 milligrams and either 100 or 200 of hydrocortisone.
You're going to get your nebulisers in there early as well. So again, back-to-back, salbutamol, hypotropium as well. And then you're going to think about your antibiotics as well. So go according to guidelines, obviously. Get your chest x-ray done. If there's a mnemonic process, you're going to go with pneumonia guidelines. If there isn't, think about your infective exacerbation, COPD. Tends to be sort of doxycycline or levofloxacin, I think, nowadays. And then, I mean, most important part in terms of the...
sort of diagnostic aspect of that acute exacerbation is going to be the ABG how much have they decompensated so are they now acidotic with a type 2 respiratory failure are they a candidate for invasive ventilation if they're very drowsy with that respiratory failure can they maintain their airway or are we going to think about non-invasive ventilation Now, we've talked together quite a few times for your sins. I say to a lot of medical students, the thing that will make you stand out even better as an F1 is if you know the next step of the condition. So, you know, I've started my inhalers, I've started the steroids, etc. Rather than going to the med bridge, help, help, you actually go, well, I'm now thinking about NIV because that makes you sound so much better. So what is NIV and when do we start to think that our patient with COPD needs NIV? So non-invasive ventilation or NIV.
Technically, it's your BiPAP, your bi-level ventilation, bi-level positive pressure. And that's used purely for the respiratory acidosis as well. And if we're going technically here, they've got to have a pH between 7.25 and 7.35. Now, what that achieves is a high in spiritual pressure and a slightly lower, and a lower expiratory pressure. And you get a tidal volume, essentially, so you're helping them blow off that CO2. Sometimes you need a fixed rate on that BiPAP, so you're achieving at least 16 breaths per minute to get rid of that CO2 and recover that acidosis.
As I say, some COPD patients may even go on to invasive ventilation, but you do have to weigh up the comorbid status of those individuals and whether or not they are a level 3 candidate, whether or not weaning from an invasive ventilation strategy is going to be possible. And what you'll see in those instances where it is, is that they'll be weaned on to NIV. And often there is that decision at the point of them having NIV acutely, whether or not they need it chronically. And generally speaking, it will be the ones who have had that acute exacerbation where they've required NIV, and they've needed to be discharged with nocturnal NIV. Yeah, and I think it's important to point out that not everybody is a candidate for NIV as well. Well, yeah, so again, whenever you're thinking about high level of care, be it level one, level two for NIV, level three for invasive ventilation, you do need to consider whether it's appropriate for that individual. Your sort of 96-year-old who has every comorbidity under the sun, and this is her 10th admission in the last couple of months, putting her through something which potentially is as stressing as NIV, which it can be, not everyone tolerates it, might not be the most suitable option.
And there's a clear distinction here then between our asthmatic patients where the ventilation is... Oh, yeah, absolutely. I mean, in an asthmatic who is even starting to have a normal CO2, so they are... tiring and not hyperventilating as much as they should, they actually need to be reviewed by the intensive care team and they would be intensive care candidates. They generally speaking are younger, this is an atopic disease, this is not your comorbid 60, 70, 80 year olds who have every cardiac risk factor and the progressive chronic nature of the disease means that they are not level 3 candidates often, whereas your asthmatics near enough always will be.
Yeah, so your patient getting NIV will only be able to continue that in a level 2, an HDU environment. Yeah, I mean, obviously there are patients, as I say, who will have NIV at home. If they are independent with it, they can come in and have it on normal. If you start it acutely, though, you need it. Acutely, it needs to be in an HDU setting. I think what I've said in previous podcasts is that we never use NIV, though, for asmatics.
So yeah, I mean, if anyone's ever seen them, it's not a particularly nice mask. If they're confused, they may not tolerate it. There's a contraindication as well. Pneumothorax, bowel obstruction, any problems with the face, if there have been injuries there as well. There is a full list of contraindications. And the other thing is that it can drop your blood pressure as well. So it is a balance, but you do need to think about if they don't have an appropriate blood pressure, is it appropriate to start NIV? You might drop it further.
gcs i think as you've already alluded to is one of those sort of relative conditions so someone has a gcs of even less than 13 it can be very difficult to get neither to understand what the niv and that very tight fitting mask is all about and get to tolerate and keep it on So we're looking primarily to the primary respiratory problem now looking at COPD. Are there any other complications that can come about that we need to keep in the back of our mind and think about? So one of the very common things is this idea of bulla. So it's a bullous lung disease and actually these bullas would occur periphery of the lung. And actually if these pop then they can pop spontaneously you get a pneumothorax. And as you've already said that is a contraindication to NIV. So a very important reason to be having a chest x-ray in all COPD patients who you might be considering NIV.
We've already said they're incredibly prone to exacerbations. They may have frequent admissions, particularly in the winter, with exacerbations. And along with that, you may see the idea of respiratory failure, either significant hypoxia or hypercapnia and hypoxia, so type 2 respiratory failure. We've talked a bit about core pulmonally, the idea that this progresses to a right-sided heart strain, heart failure. Again, it's a chronic condition, so you get that hypertrophy and failure of the right side of the heart.
One thing we haven't mentioned yet is the idea of secondary polycythemia. So the idea that that chronic hypoxia is causing overproduction of the red blood cells to increase that oxygen carrying capacity. So you'll see people with HBs of 180, 190. And this can either cause symptoms such as headaches or even just increase their risk of venous thromboembolism because of the sticky nature of the blood. Plus they may be not very active as well. Well, yeah, exactly. And one thing just to think about, not necessarily a complication of COPD. It doesn't progress to carcinoma, but that smoking history may...
cause a carcinoma and whilst they're isolated people may not recognise the shortness of breath or hemoptysis as red flag symptoms if they've already got a sort of chronic progressive lung disease so if symptoms are changing things are new hemoptysis always being a red flag symptom it's worth thinking about the more sinister diagnoses I mean, that concept of the bullet of a secondary pneumothorax is something we explored in the spontaneous pneumothorax podcast. And yeah, just anecdotally, we had a gentleman who was brought in a week following a discharge after having a secondary pneumothorax. And he came back in very short of breath and known COPD and shocking gas. And we're bringing the iPad machine ready. But I don't like how quiet one side of his chest is. And luckily, we did get the chest x-ray and he was a pneumothorax.
the chest surgery they're very very important absolutely and hopefully in that case as soon as you put that chest strain in you would actually that's the appropriate treatment thing about NIV is it's actually it's a holding measure really you should only really be putting someone on NIV if you're expecting them to be getting off it are you treating the underlying reason for the exacerbation so yeah how long are patients usually on NIV for in your experience it'll depend it really does I mean we get a whole mix of patients we get all the COPD patients but you'll also get the neuromuscular patients as well and when you think about type 2 respiratory failure in a neuromuscular patient now that's obviously it a fully progressive disease and actually it's not exacerbations that are making them decompensate it's the muscular failure so they stay on it they sort of progressed 24-7 NIV. Now COPD patients though, they may be on it for sort of 24 hours for a couple of days. It may not need to be that long. Some people come in, they have it overnight and they're off it by the next day. But what you'll see for that weaning process is that they might be on and off it for a couple of days. And you wean by time rather than pressures. So it might be a couple of hours off, a couple of hours on, and then day off, night on, and then sort of wean from that perspective. And you'll be doing serial ABGs during that time? That's benefit of heart lines. And the other reason why it needs to be in a level 1, level 2 area is that we can use arterial tracing and those arterial...
access points to get serial ABGs. You've mentioned other causes of type 2 respiratory failure as well and in the A&E environment I've seen it in patients with Well, no, there was a patient who came in with an opiate overdose, but he actually went on to be ventilated. He added a massive CO2 of 24 through opiate overdose. But I've also seen NIV starting patients with really bad CCF, really bad congestive cardiac failure, and showing a type 2 respiratory failure on the gas, and NIV being a benefit to those patients as well. I think the baseline for NIV is that if they are a type 2 picture, BiPAP is appropriate. We know that CPAP can be used for pulmonary edema heart failure, but as soon as you go into that...
hypercapnic heart failure and sometimes it will be an overlap syndrome you'll either see them have a bit of obesity hyperventilation on the top of that or even COPD again we're talking about the risk factors being the same here then you'd use your BiPAP so irrespective of cause BiPAP is possibly an option in a respiratory acidosis that was the Take Orally COPD podcast you can find us on Facebook and Twitter where we'll put up links to guidelines mentioned and you can contact us to suggest topics you'd like to see covered in future episodes more information on education and research opportunities within emergency medicine acute medicine and major trauma you can find NUH Dream on both Facebook and Twitter